We are live on !
Find out more
WFG
Wormser Freres Gestion Portfolio holdings
AUM
$181M
Turnover
14.86%
1-Year Est. Return
17.24%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+17.24%
3 Year Est. Return
+67.36%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$181M
AUM Growth
+$3.74M
(+2.1%)
Cap. Flow
-$444K
Cap. Flow % of AUM
Cap. Flow %
-0.25%
Top 10 Holdings %
Top 10 Hldgs %
61.37%
Holding
74
New
8
Increased
31
Reduced
20
Closed
3
Avg Time Held
1.4
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$4.36M |
| 2 |
Xylem
XYL
|
+$3.45M |
| 3 |
MSCI
MSCI
|
+$3.26M |
| 4 |
NVIDIA
NVDA
|
+$2.81M |
| 5 |
Vertiv
VRT
|
+$688K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$4.11M |
| 2 |
Cadence Design Systems
CDNS
|
+$3.93M |
| 3 |
Palo Alto Networks
PANW
|
+$3.51M |
| 4 |
Alcon
ALC
|
+$2.57M |
| 5 |
Amazon
AMZN
|
+$1.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.76% |
| 2 | Healthcare | 19.93% |
| 3 | Industrials | 11.96% |
| 4 | Financials | 10.3% |
| 5 | Communication Services | 8.26% |
Similar funds
AMAL
MIM
Wormser Freres Gestion's Q3 2026 Portfolio in Review
As of Q3 2026, Wormser Freres Gestion held 74 positions worth $181M, up 2.1% from $177M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Wormser Freres Gestion's Q3 2026 filing shows 8 new, 31 increased, 20 reduced and 3 closed positions. Its largest new stake was AstraZeneca: 2,149 shares worth $351K. The largest sale was Thermo Fisher Scientific, an estimated $4.11M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Healthcare and Industrials.
- Wormser Freres Gestion's largest Q3 2026 buy was AstraZeneca: 2,149 shares worth $351K.
- Wormser Freres Gestion added most to Lam Research in Q3 2026, an estimated $4.36M increase.
- Wormser Freres Gestion's biggest Q3 2026 reduction was Thermo Fisher Scientific, cutting an estimated $4.11M.
- Wormser Freres Gestion fully exited KLA in Q3 2026, selling an estimated $1M.
- Wormser Freres Gestion's ten largest holdings make up 61% of its $181M portfolio in Q3 2026.
- Wormser Freres Gestion opened 8 new positions and closed 3 in Q3 2026.
- Wormser Freres Gestion's portfolio value rose 2.1% quarter-over-quarter to $181M.
Based on Wormser Freres Gestion's 13F filing for Q3 2026, filed 21 Oct 2026.